Volume 123, Issue 3 , Pages 466-474, March 2002
Molecular assessment of lymph nodes in patients with resected stage I non–small cell lung cancer: Preliminary results of a prospective study☆☆☆★
To access this article, please choose from the options below
☆ Supported in part by the American Association for Thoracic Surgery Research Scholarship, Lung Spore grant CA-58184-01, and Public Health Service grant K08CA76452-01 from the National Cancer Institute, National Institutes of Health, Department of Health and Human Services.
☆☆ Read at the Eighty-first Annual Meeting of The American Association for Thoracic Surgery, San Diego, Calif, May 6-9, 2001.
★ Address for reprints: Steven A. Ahrendt, MD, Department of Surgery, University of Rochester, 601 Elmwood Ave, Rochester, NY 14642 (E-mail: Steven_Ahrendt@urmc. rochester.edu
PII: S0022-5223(02)90100-5
doi:10.1067/mtc.2002.120343
© 2002 American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.
Refers to article:
- Molecular biologic substaging of non-small cell lung cancer
Volume 123, Issue 3 , Pages 466-474, March 2002
